Molecular Basis for Modulation of the p53 Target Selectivity by KLF4

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Brandt, Tobias ^a,b   Townsley, Fiona M ^a   Teufel, Daniel P ^a   Freund, Stefan M V ^a   Veprintsev, Dmitry B ^a,c,d  

^a MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^b MAX PLANCK INSTITUTE OF BIOPHYSICS   (Germany)

^c PAUL SCHERRER INSTITUTE   (Switzerland)

^d ETH ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

KRUPPEL LIKE FACTOR 4; PROTEIN P53;

AMINO TERMINAL SEQUENCE; ANISOTROPY; ARTICLE; BINDING AFFINITY; BIOPHYSICS; CELL CYCLE ARREST; COMPUTER MODEL; CONTROLLED STUDY; DNA PROTEIN COMPLEX; DNA RESPONSIVE ELEMENT; FLUORESCENCE; GENE CONTROL; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTEIN ANALYSIS; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; TRANSCRIPTION REGULATION; ZINC FINGER MOTIF;

COMPUTATIONAL BIOLOGY; DNA; GENE EXPRESSION REGULATION; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MODELS, MOLECULAR; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN TRANSPORT; RESPONSE ELEMENTS; SUBSTRATE SPECIFICITY; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53; ZINC FINGERS;

EID: 84868135386     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0048252     Document Type: Article

References (55)

1. Hamroun D, Kato S, Ishioka C, Claustres M, Beroud C, et al. (2006) The UMD TP53 database and website: update and revisions. Hum Mutat 27: 14-20.
2. Murray-Zmijewski F, Slee EA, Lu X, (2008) A complex barcode underlies the heterogeneous response of p53 to stress. Nat Rev Mol Cell Biol 9: 702-712.
3. Vousden KH, Prives C, (2009) Blinded by the Light: The Growing Complexity of p53. Cell 137: 413-431.
4. Menendez D, Inga A, Resnick MA, (2009) The expanding universe of p53 targets. Nat Rev Cancer 9: 724-737.
5. Wei CL, Wu Q, Vega VB, Chiu KP, Ng P, et al. (2006) A Global Map of p53 Transcription-Factor Binding Sites in the Human Genome. Cell 124: 207-219.
6. Veprintsev DB, Fersht AR, (2008) Algorithm for prediction of tumour suppressor p53 affinity for binding sites in DNA. Nucleic Acids Res 36: 1589-1598.
7. Smeenk L, van Heeringen SJ, Koeppel M, van Driel MA, Bartels SJ, et al. (2008) Characterization of genome-wide p53-binding sites upon stress response. Nucleic Acids Res 36: 3639-3654.
8. Brandt T, Petrovich M, Joerger AC, Veprintsev DB, (2009) Conservation of DNA-binding specificity and oligomerisation properties within the p53 family. BMC Genomics 10: 628.
9. Dotsch V, Bernassola F, Coutandin D, Candi E, Melino G, (2010) p63 and p73, the ancestors of p53. Cold Spring Harb Perspect Biol 2: a004887.
10. Beckerman R, Prives C, (2010) Transcriptional regulation by p53. Cold Spring Harb Perspect Biol 2: a000935.
11. Kitayner M, Rozenberg H, Kessler N, Rabinovich D, Shaulov L, et al. (2006) Structural basis of DNA recognition by p53 tetramers. Mol Cell 22: 741-753.
12. Weinberg RL, Freund SM, Veprintsev DB, Bycroft M, Fersht AR, (2004) Regulation of DNA Binding of p53 by its C-terminal Domain. J Mol Biol 342: 801-811.
13. El-Deiry WS, Kern SE, Pietenpol JA, Kinzler KW, Vogelstein B, (1992) Definition of a consensus binding site for p53. Nat Genet 1: 45-49.
14. McKinney K, Mattia M, Gottifredi V, Prives C, (2004) p53 linear diffusion along DNA requires its C terminus. Mol Cell 16: 413-424.
15. Tafvizi A, Huang F, Fersht AR, Mirny LA, van Oijen AM, (2011) A single-molecule characterization of p53 search on DNA. Proc Natl Acad Sci U S A 108: 563-568.
16. Petty TJ, Emamzadah S, Costantino L, Petkova I, Stavridi ES, et al. (2011) An induced fit mechanism regulates p53 DNA binding kinetics to confer sequence specificity. Embo J 30: 2167-2176.
17. Melero R, Rajagopalan S, Lazaro M, Joerger AC, Brandt T, et al. (2011) Electron microscopy studies on the quaternary structure of p53 reveal different binding modes for p53 tetramers in complex with DNA. Proc Natl Acad Sci U S A 108: 557-562.
18. Arbely E, Natan E, Brandt T, Allen MD, Veprintsev DB, et al. (2011) Acetylation of lysine 120 of p53 endows DNA-binding specificity at effective physiological salt concentration. Proc Natl Acad Sci U S A 108: 8251-8256.
19. Rowland BD, Peeper DS, (2006) KLF4, p21 and context-dependent opposing forces in cancer. Nat Rev Cancer 6: 11-23.
20. Yoon HS, Chen X, Yang VW, (2003) Kruppel-like factor 4 mediates p53-dependent G1/S cell cycle arrest in response to DNA damage. J Biol Chem 278: 2101-2105.
21. Zhou Q, Hong Y, Zhan Q, Shen Y, Liu Z, (2009) Role for Kruppel-like factor 4 in determining the outcome of p53 response to DNA damage. Cancer Res 69: 8284-8292.
22. Ghaleb AM, Katz JP, Kaestner KH, Du JX, Yang VW, (2007) Kruppel-like factor 4 exhibits antiapoptotic activity following gamma-radiation-induced DNA damage. Oncogene 26: 2365-2373.
23. Zhang W, Geiman DE, Shields JM, Dang DT, Mahatan CS, et al. (2000) The gut-enriched Kruppel-like factor (Kruppel-like factor 4) mediates the transactivating effect of p53 on the p21WAF1/Cip1 promoter. J Biol Chem 275: 18391-18398.
24. Nikolova PV, Henckel J, Lane DP, Fersht AR, (1998) Semirational design of active tumor suppressor p53 DNA binding domain with enhanced stability. ProcNatlAcadSciUSA 95: 14675-14680.
25. Veprintsev DB, Freund SM, Andreeva A, Rutledge SE, Tidow H, et al. (2006) Core domain interactions in full-length p53 in solution. Proc Natl Acad Sci U S A 103: 2115-2119.
26. Joerger AC, Allen MD, Fersht AR, (2004) Crystal Structure of a Superstable Mutant of Human p53 Core Domain: insights into the mechanism of rescuing oncogenic mutations. J Biol Chem 279: 1291-1296.
27. Weinberg RL, Veprintsev DB, Fersht AR, (2004) Cooperative binding of tetrameric p53 to DNA. J Mol Biol 341: 1145-1159.
28. Teufel DP, Bycroft M, Fersht AR, (2009) Regulation by phosphorylation of the relative affinities of the N-terminal transactivation domains of p53 for p300 domains and Mdm2. Oncogene 28: 2112-2118.
29. Schuck P, Perugini MA, Gonzales NR, Howlett GJ, Schubert D, (2002) Size-distribution analysis of proteins by analytical ultracentrifugation: strategies and application to model systems. Biophys J 82: 1096-1111.
30. Goddard TD, Kneller DG SPARKY 3. SPARKY 3: University of California, San Francisco.
31. Jung YS, Zweckstetter M, (2004) Mars - robust automatic backbone assignment of proteins. J Biomol NMR 30: 11-23.
32. Chen X, Xu H, Yuan P, Fang F, Huss M, et al. (2008) Integration of External Signaling Pathways with the Core Transcriptional Network in Embryonic Stem Cells. Cell 133: 1106-1117.
33. Tidow H, Melero R, Mylonas E, Freund SM, Grossmann JG, et al. (2007) Quaternary structures of tumor suppressor p53 and a specific p53 DNA complex. Proc Natl Acad Sci U S A 104: 12324-12329.
34. Wells M, Tidow H, Rutherford TJ, Markwick P, Jensen MR, et al. (2008) Structure of tumor suppressor p53 and its intrinsically disordered N-terminal transactivation domain. Proc Natl Acad Sci U S A 105: 5762-5767.
35. Teufel DP, Freund SM, Bycroft M, Fersht AR, (2007) Four domains of p300 each bind tightly to a sequence spanning both transactivation subdomains of p53. Proc Natl Acad Sci U S A 104: 7009-7014.
36. Schuetz A, Nana D, Rose C, Zocher G, Milanovic M, et al. (2011) The structure of the Klf4 DNA-binding domain links to self-renewal and macrophage differentiation. Cellular and molecular life sciences: CMLS 68: 3121-3131.
37. Weinberg RL, Veprintsev DB, Bycroft M, Fersht AR, (2005) Comparative binding of p53 to its promoter and DNA recognition elements. J Mol Biol 348: 589-596.
38. Ahn J, Prives C, (2001) The C-terminus of p53: the more you learn the less you know. Nat Struct Biol 8: 730-732.
39. Friedler A, Veprintsev DB, Freund SM, von Glos KI, Fersht AR, (2005) Modulation of binding of DNA to the C-terminal domain of p53 by acetylation. Structure 13: 629-636.
40. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, et al. (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825.
41. Miyashita T, Reed JC, (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80: 293-299.
42. Jordan JJ, Menendez D, Inga A, Noureddine M, Bell DA, et al. (2008) Noncanonical DNA motifs as transactivation targets by wild type and mutant p53. PLoS Genet 4: e1000104.
43. Rajagopalan S, Andreeva A, Rutherford TJ, Fersht AR, (2010) Mapping the physical and functional interactions between the tumor suppressors p53 and BRCA2. Proc Natl Acad Sci U S A 107: 8587-8592.
44. Boehme KA, Blattner C, (2009) Regulation of p53-insights into a complex process. Crit Rev Biochem Mol Biol 44: 367-392.
45. Candau R, Scolnick DM, Darpino P, Ying CY, Halazonetis TD, et al. (1997) Two tandem and independent sub-activation domains in the amino terminus of p53 require the adaptor complex for activity. Oncogene 15: 807-816.
46. Venot C, Maratrat M, Sierra V, Conseiller E, Debussche L, (1999) Definition of a p53 transactivation function-deficient mutant and characterization of two independent p53 transactivation subdomains. Oncogene 18: 2405-2410.
47. Lavin MF, Gueven N, (2006) The complexity of p53 stabilization and activation. Cell Death Differ 13: 941-950.
48. Bulavin DV, Saito S, Hollander MC, Sakaguchi K, Anderson CW, et al. (1999) Phosphorylation of human p53 by p38 kinase coordinates N-terminal phosphorylation and apoptosis in response to UV radiation. EMBO J 18: 6845-6854.
49. Taira N, Nihira K, Yamaguchi T, Miki Y, Yoshida K, (2007) DYRK2 is targeted to the nucleus and controls p53 via Ser46 phosphorylation in the apoptotic response to DNA damage. Mol Cell 25: 725-738.
50. Dauth I, Kruger J, Hofmann TG, (2007) Homeodomain-interacting protein kinase 2 is the ionizing radiation-activated p53 serine 46 kinase and is regulated by ATM. Cancer Res 67: 2274-2279.
51. D'Orazi G, Cecchinelli B, Bruno T, Manni I, Higashimoto Y, et al. (2002) Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis. Nat Cell Biol 4: 11-19.
52. Hofmann TG, Moller A, Sirma H, Zentgraf H, Taya Y, et al. (2002) Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2. Nat Cell Biol 4: 1-10.
53. Yeh PY, Chuang SE, Yeh KH, Song YC, Chang LL, et al. (2004) Phosphorylation of p53 on Thr55 by ERK2 is necessary for doxorubicin-induced p53 activation and cell death. Oncogene 23: 3580-3588.
54. Lee CW, Ferreon JC, Ferreon AC, Arai M, Wright PE, (2010) Graded enhancement of p53 binding to CREB-binding protein (CBP) by multisite phosphorylation. Proc Natl Acad Sci U S A 107: 19290-19295.
55. Di Lello P, Jenkins LM, Jones TN, Nguyen BD, Hara T, et al. (2006) Structure of the Tfb1/p53 complex: Insights into the interaction between the p62/Tfb1 subunit of TFIIH and the activation domain of p53. Mol Cell 22: 731-740.